Drug Shortage Report for TEVA-ZOPICLONE
| Report ID | 130282 |
| Drug Identification Number | 02242481 |
| Brand name | TEVA-ZOPICLONE |
| Common or Proper name | TEVA-ZOPICLONE 7.5MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | ZOPICLONE |
| Strength(s) | 7.5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | N05CF |
| ATC description | HYPNOTICS AND SEDATIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-12-16 |
| Estimated end date | 2021-07-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2021-04-01 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.